Ideal Ferritin Level to Start EPO in CKD
Before initiating erythropoietin (EPO) therapy in CKD patients, ferritin should be >100 ng/mL and transferrin saturation (TSAT) should be >20%. 1
Iron Requirements Vary by CKD Population
The specific ferritin threshold differs based on dialysis status:
Non-Dialysis and Peritoneal Dialysis CKD Patients
- Ferritin >100 ng/mL and TSAT >20% are required before starting ESA therapy 1
- These patients can often maintain adequate iron stores with oral supplementation, though many will require intravenous iron 2
Hemodialysis CKD Patients
- Ferritin >200 ng/mL and TSAT >20% (or CHr >29 pg/cell) are the recommended targets before and during ESA therapy 1
- Higher thresholds are needed because hemodialysis patients have ongoing blood losses that exceed what oral iron can replace 2
- Studies demonstrate that maintaining ferritin at 200-400 ng/mL in hemodialysis patients results in 28% lower ESA dose requirements compared to maintaining ferritin at lower levels 3
Rationale for These Thresholds
Iron stores must be adequate before starting EPO because erythropoietin-stimulated erythropoiesis dramatically increases iron demand. 2 Without sufficient iron availability, patients will develop functional iron deficiency even if they have normal baseline iron stores. 2
- EPO therapy requires approximately 150 mg of iron for every 1 g/dL increase in hemoglobin 4
- Patients with TSAT <20% or ferritin <100 ng/mL frequently fail to respond adequately to ESA therapy 1, 2
- Even patients with TSAT >20% may still have absent bone marrow iron stores, indicating functional iron deficiency 3, 5
Monitoring Strategy During ESA Initiation
Check TSAT and ferritin monthly during the initiation phase of EPO therapy until target hemoglobin (11-12 g/dL) is reached. 2
- After achieving stable hemoglobin, monitor iron parameters at least every 3 months 2
- The hemoglobin rise should be 1.0-2.0 g/dL per month and should not exceed 1 g/dL in any 2-week period 1
Common Pitfalls to Avoid
Do not start EPO without first ensuring adequate iron stores. 1 This is the most common cause of ESA hyporesponsiveness and leads to unnecessarily high EPO doses, increased costs, and potential adverse effects. 2
Ferritin can be falsely elevated in CKD due to inflammation (it is an acute-phase reactant), so consider measuring C-reactive protein if ferritin seems disproportionately high relative to TSAT. 6 Transferrin saturation is more reliable than ferritin alone for assessing iron availability because it is less affected by inflammation. 6
Upper safety limits exist: There is insufficient evidence to recommend IV iron if ferritin exceeds 500 ng/mL in non-dialysis patients 1 or 800 ng/mL in hemodialysis patients. 2, 6 Patients are unlikely to respond with further hemoglobin increases if TSAT reaches 50% or ferritin reaches 800 ng/mL. 2
Algorithm for Iron Repletion Before EPO
If iron parameters are inadequate before starting EPO:
- For hemodialysis patients: Administer 1.0 g IV iron over 8-10 weeks (typically 100-125 mg weekly) 2
- For non-dialysis/peritoneal dialysis patients: Trial oral iron (at least 200 mg elemental iron daily) first; if inadequate response after 3 months, switch to IV iron 2, 4
- Reassess iron parameters after repletion and confirm ferritin and TSAT meet thresholds before initiating ESA 1